June 30, 2026 · Form 4 insider transaction
Lopez Carlos Luis bought 2,314 shares of Niagen Bioscience, Inc. at $2.71 per share, a transaction worth $6.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 8 days after the transaction.
Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d).